Julian Bailes
Director Técnico/Científico/I+D en BLUE WATER VENTURES INTERNATIONAL, INC. .
Cargos activos de Julian Bailes
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Director/Miembro de la Junta | - | - |
| Director Técnico/Científico/I+D | - | - | |
Psycheceutical, Inc.
 Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Director/Miembro de la Junta | 10/01/2023 | - |
| Director Técnico/Científico/I+D | 10/01/2023 | - |
Historial de carrera de Julian Bailes
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorial
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
| Empresas privadas | 1 |
|---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Julian Bailes
- Experiencia
